Received Apr 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | LG |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | LG |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | LG |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | LG |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | LG |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | LG |
Patient present with vaccine administrations in bilateral thigh on 04/24/2025. Mother did not bring a detailed record, just a general list of what was given. Yesterday she noticed redness surrounding a white central area that was new. Today the redness is larger, hard (not fluctuant) and erythematic. 1+ edema measures 2 inches by 2.75 inches with central pale area that measure 0.5 inch and 2 prominent puncture areas noted. Patient indicates that it is tender to touch and itchy. The other leg has very slight pink area, no edema. Recommended Loratidine 2.5 mg daily and to reach out to PCP to share the reaction. Notified mother that she may get a call for more information, she agreed.
none
none
none
none
none